United States Food and Drug Administration (USFDA) has conducted an inspection of Jeevan Scientific Technology’s bioanalytical facility, at Manikonda, Hyderabad. The purpose of the inspection was to review the BA/BE studies as well as the operations, systems and procedures. The inspection was conducted during July 20, 2026 to July 24, 2026 and closed with No Observations (Zero 483s).
The inspector concluded that the entire company’s team is well trained, knowledgeable and experienced with International Regulatory requirements and Good practices, working within an adequately designed infrastructure and that the organization is compliant with all applicable regulations.
Jeevan Scientific Technology was incorporated on February 2, 1999 to carry on the business Clinical research, Data management services. The company is an Independent Clinical Contract Research Organization, offering reliable, cost-effective and technology-driven clinical research solutions to various Clients across the globe.
| Company Name | CMP |
|---|---|
| TCS | 2431.90 |
| Infosys | 1156.10 |
| HCL Technologies | 1353.20 |
| Wipro | 186.35 |
| Tech Mahindra | 1660.15 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: